Stock-Based Compensation (Tables)

12 Months Ended

Oct. 30, 2022

Share-Based Payment Arrangement [Abstract]

Schedule of reconciliation of the number of options outstanding and exercisable

A reconciliation of the number of options outstanding and exercisable as of October 30, 2022, is: 

	Shares (in thousands)	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in thousands)
Stock Options Outstanding at October 31, 2021	19,022	$	33.49
Granted	1,358	43.19
Exercised	(3,845)	22.17
Forfeited	(403)	40.06
Expired	(1)	40.59
Stock Options Outstanding at October 30, 2022	16,130	$	36.85	4.9	$	163,808
Stock Options Exercisable at October 30, 2022	10,816	$	34.56	3.9	$	134,370

Schedule of weighted-average grant date fair value of stock options granted and the total intrinsic value of options exercised

The weighted-average grant date fair value of stock options granted and the total intrinsic value of options exercised during each of the past three fiscal years, are: 

	Fiscal Year Ended
	October 30,		October 31,		October 25,
In thousands, except per share amounts	2022		2021		2020
Weighted-average Grant Date Fair Value	$	7.09	$	7.52	$	7.72
Intrinsic Value of Exercised Options	109,745		94,108		182,821

Schedule of weighted-average assumptions used to calculate fair value of each option award

The fair value of each option award is calculated on the date of grant using the Black-Scholes valuation model utilizing the following weighted-average assumptions:

	Fiscal Year Ended
	October 30,		October 31,		October 25,
	2022		2021		2020
Risk-free Interest Rate	1.6	%	1.0	%	1.7	%
Dividend Yield	2.4	%	2.1	%	2.0	%
Stock Price Volatility	20.4	%	20.0	%	19.0	%
Expected Option Life	7.5 years		7.4 years		7.5 years

Schedule of reconciliation of the nonvested shares

A reconciliation of the restricted stock units as of October 30, 2022, is:

	Shares (in thousands)	Weighted- Average Grant Date Fair Value		Weighted-Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in thousands)
Restricted Stock Units Outstanding at October 31, 2021	385	$	46.81
Granted	362	44.14
Dividend Equivalents	9	50.32
Vested	(41)	45.68
Forfeited	(34)	44.76
Restricted Stock Units Outstanding at October 30, 2022	681	$	45.53	1.5	$	31,972

A reconciliation of the restricted shares as of October 30, 2022, is: 

In thousands, except per share amounts	Shares	Weighted- Average Grant Date Fair Value
Restricted Shares Outstanding at October 31, 2021	38	$	46.92
Granted	37	47.11
Vested	(38)	46.92
Restricted Shares Outstanding at October 30, 2022	37	$	47.11

Schedule of the weighted-average grant date fair value and fair value of nonvested shares granted

The weighted-average grant date fair value of restricted stock units granted and the total fair value of restricted stock units granted during each of the past three fiscal years, are:

	Fiscal Year Ended
	October 30,		October 31,		October 25,
In thousands, except per share amounts	2022		2021		2020
Weighted-average Grant Date Fair Value	$	44.14	$	47.52	$	45.88
Fair Value of Restricted Stock Units Granted	15,980		10,699		9,383
Fair Value of Restricted Stock Units Vested	$	1,893	$	1,460	$	839

The weighted-average grant date fair value of restricted shares granted, the total fair value of restricted shares granted, and the fair value of shares that have vested during each of the past three fiscal years are:

	Fiscal Year Ended
	October 30,		October 31,		October 25,
In thousands, except per share amounts	2022		2021		2020
Weighted-average Grant Date Fair Value	$	47.11	$	46.92	$	47.29
Fair Value of Restricted Shares Granted	1,760		1,760		1,973
Fair Value of Restricted Shares Vested	$	1,760	$	2,133	$	1,974